BOULDER, Colo. - (Business Wire) The Boulder Innovation Center (BIC), as part its mission to commercialize scientific inventions developed at the University of Colorado, has received financial support from CU-Boulder’s CIMB (Colorado Initiative in Molecular Biotechnology) to expand its Bioscience Program. Tim Prodanovich, BIC Bioscience Program Manager, will be expanding his work with CIMB faculty to identify promising commercial applications related to inventions resulting from their research. CIMB is lead by Nobel Laureate and CU Distinguished Professor Tom Cech and Director Dr. Leslie Leinwand. Prodanovich will support commercialization programs in coordination with the CIMB and CU’s Tech Transfer Office, focusing on Proof-of-Concept Proposal development; business advisor, mentor and executive team recruitment; feasibility studies and business planning; and capital formation strategies.
The CIMB was founded by CU-Boulder in 2003 to foster research, teaching and technology development at the interfaces of the life sciences, physical sciences, math, computational sciences and engineering. A major research and teaching facility being built in the CU-Boulder Research Park will house the CIMB as well as the Department of Chemical and Biological Engineering and the Biochemistry Division. The 60 faculty and more than 600 researchers from a wide variety of science, engineering and medical disciplines will collaborate with each other and the biotech industry on high-tech solutions to biomedical problems.
“We are pleased to partner with the Boulder Innovation Center’s Bioscience Program in its efforts to commercialize inventions and technologies developed through the Colorado Initiative in Molecular Biotechnology,” said Cech. “Our shared goal is to bolster biotechnology innovation in the region.”
“With so many innovations on the horizon, investment in bioscience is poised for growth,” said Tim Bour, BIC executive director. “CU research excels in this field, and the BIC’s Bioscience Program is ready to ramp up our support to help commercialize these promising new technologies.”
“From new technologies and companies, to workforce development and equity funding, Colorado’s bioscience cluster is growing fast on every front,” said Prodanovich. “The BIC is looking forward to accelerating the CIMB’s commitment to the research commercialization process.”
Metzger Associates
John Metzger, 303-641-1062
john@metzger.com
